Online
AstraZeneca Pharma
BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | Pharmaceuticals
| Finished Products | --------------------------- in Rs. Cr. --------------------------- | Dec 2008 | |||
| Product Name | Unit | Installed Capacity |
Production Quantity |
Sales Quantity |
Sales Value |
| Tablets & Capsules (Formulations) | Millions Numbers | 690 | 418.73 | 473.43 | 132.91 |
| Formulation (Injectibles) | Millions Numbers | 33 | 19.87 | 19.75 | 121.74 |
| Service Income | - | NA | NA | NA | 14.50 |
| Inhalation Products | - | NA | 0.17 | 0.18 | 3.37 |
| Processing Charges | - | NA | NA | NA | 1.24 |
| Dry Powders | - | NA | NA | 0.25 | 0.90 |
| Scrap | - | NA | NA | NA | 0.33 |
| Other Services | - | NA | NA | NA | 0.00 |
| Ointments | - | NA | NA | NA | 0.00 |
| Liquids (Formulations) | - | NA | NA | NA | 0.00 |
| Formulations (Tablets) Traded | - | NA | NA | NA | 0.00 |
| Formulations (Ointments) | - | NA | NA | NA | 0.00 |
| Formulation Capsules/Tablets | - | NA | NA | NA | 0.00 |
| Bulk Drugs And Chemicals | - | NA | NA | NA | 0.00 |
| Total | 274.99 | ||||
 | |||||
| Source : Religare Technova | |||||
| |||||
